drugset / Trial / NCT02625779

Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression

NCT02625779

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research is aimed to investigate the efficacy and safety of the creatine and cytidine augmentation in treating bipolar depression and to evaluate changes in relevant brain biochemical metabolism using proton and phosphorous magnetic resonance spectroscopy.

Timeline

Start
2016-03-01
Primary completion
2017-04-30
Completion
2017-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine-containing Drug Unknown 5 g
Subject Cytidine-containing Drug Unknown 2 g
Comparator Valproate Small molecule 300 mg

Indications